Frank Gerberick Joins RenovaCare's Board of Advisors
September 24, 2019 at 01:30 pm
Share
RenovaCare, Inc. announced the appointment of Dr. Frank Gerberick to its Board of Advisors to help advance the Company’s SkinGun™ cell spray technology for the regeneration of human skin. Following the completion of his postdoctoral fellowship at The Johns Hopkins University School of Medicine, Dr. Gerberick commenced a long-spanning career at Procter & Gamble. Dr. Gerberick was appointed to the Procter & Gamble’s Victor Mills Society. At P&G, he focused his research career in the areas of dermatotoxicology, immunotoxicology and phototoxicology.
RenovaCare, Inc. is a clinical-stage biotechnology company. The Company is focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company through its wholly owned subsidiary, RenovaCare Sciences Corp. is focusing on the research, development and commercialization of autologous (using a patientâs own cells) cellular therapies that can be used for medical and aesthetic applications. The Companyâs CellMist System is a cell isolation procedure that enzymatically renders stem cells from the patientâs own skin or other tissues. The resulting stem cell suspension is administered topically from the Companyâs novel solution sprayer device (the SkinGun) as a cell therapy for wounds including burns to facilitate healing. Its SkinGun spray device is an advanced technology, using a gentle positive-pressure air stream to spray the CellMist Solution onto wounds.
RENOVACARE, INC. 
